Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

NCT04467983 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Denosumab Injection
DRUG: Abaloparatide

Sponsor

Hospital for Special Surgery, New York

Collaborators

[object Object]
[object Object]